1. Gadow, K.D., and Poling, A. G. (1988).Pharmacotherapy and mental Retardation, College Hall Publication, San Diego.
2. Intagliata, J., and Rinck, C. (1985). Psychoactive drug use in public and community facilities for mentally retarded people.Psychopharmacol. Bull. 21: 268–268.
3. Jeste, D. V., and Wyatt, R. J. (1982).Understanding and Treating Tardive Dyskinesia, New York: Guilford.
4. Kalachnik, J. E., Harder, S. R., Kidd-Nielson, N. P., Errickson, E., Doebler, M., and Sprague, R. L. (1984). Persistent tardive dyskinesia in randomly assigned neuroleptic reduction, neuroleptic nonreduction, and no neuroleptic history groups: Preliminary results.Psychopharmacol. Bull. 20: 27–32.
5. Kastrup, E. K., and Olan, B. R. (eds.) (1988).Drug Facts and Comparisons, J. B. Lippincott, New York.